THE END FUND

Updated 29 days ago
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
  • Active - 06350698 (CH)
  • Age: 17 years
  • ID: 47007599/37
USA: 2 Park Avenue
, 28th Floor
, New York, NY, 10016
• 82990 - Other business support service activities n.e.c.
The END Fund is dedicated to fighting the five most prevalent neglected tropical diseases, which affect over 1.6 billion people globally... The END Fund Inc. is a 501(c)(3), tax-exempt charitable organization registered in the United States (EIN 27-3941186). The END Fund is a company limited by guarantee registered in England and Wales (company number 6350698) and a UK registered charity (number 1122574). The END Fund Kenya is a a non-governmental organization registered in the Republic of Kenya as NGO-POFQMD... The END Fund's staff is dedicated to mobilizing resources and providing programatic assistance to help our partners end neglected tropical diseases.
Also known as: END Fund, END Fund Inc., END Fund Kenya, The END Fund Inc.
Previous names: CAPITAL FOR GOOD
Primary location: New York United States
Associated domains: end.fund, end.net, end.news, end.org.uk, end10.com, end10.net, end10.org, end6.net, end9.org, endfund.co.nz, endfund.net, endfund.net.nz, endfund.org, endfund.org.uk, theendfund.org
  • 0
  • 0
Interest Score
6
HIT Score
0.75
General

UK Company Data

Company number
06350698
Account category
FULL
Account ref. day
31
Account ref. month
12
Accounts next due date
2024-09-30
Accounts last made up date
2022-12-31
Returns next due date
2016-09-19
Returns last made up date
2015-08-22
Num. mort. charges
0
Num. mort. outstanding
0
Num. mort. part. satisfied
0
Num. mort. satisfied
0
Num. gen. partners
0
Num. lim. partners
0
Domain
end.org

Actual
end.org

IP
104.21.42.227, 172.67.167.168

Status
OK

Category
Company

People Also Viewed


  1. ARLO HOMES LIMITED
  2. OPC PHARMA - opcpharma.com
  3. GRIFFITH LAWN CARE - griffithlawncare.com
  4. FORBES INC LTD
  5. EGHAM FLOOR SANDING - eghamfloorsanding.co.uk
0 comments Add a comment